The quarter's dismal performance stemmed from a toxic combination of compressed margins, elevated interest costs, and an extraordinary negative tax charge. Despite revenue growing 15.73% year-on-year to ₹7,882.33 crores, operating margins contracted sharply to 7.76% from 10.78% in Q4 FY25, reflecting intense input cost pressures and subdued realisations. The company's profit before tax swung to a loss of ₹162.34 crores, burdened by a 76.89% negative tax rate that amplified the bottom-line damage. This marks the first quarterly loss in recent years for the Murugappa Group company, raising questions about the sustainability of its diversified business model.
With the stock trading 38.70% below its 52-week high of ₹1,246.45 and underperforming the Sensex by 14.88 percentage points over the past year, EID Parry faces a critical juncture. The company's valuation grade has deteriorated to "Very Expensive" despite the sharp correction, whilst technical indicators remain firmly bearish. For investors, the key question is whether this represents a temporary cyclical trough or the beginning of a more prolonged earnings downturn.
| Quarter | Mar'26 | Dec'25 | Sep'25 | Jun'25 | Mar'25 | Dec'24 | Sep'24 |
|---|---|---|---|---|---|---|---|
| Net Sales (₹ Cr) | 7,882.33 | 10,312.20 | 11,624.44 | 8,723.68 | 6,811.12 | 8,720.35 | 9,330.35 |
| QoQ Growth | -23.56% | -11.29% | +33.25% | +28.08% | -21.89% | -6.54% | — |
| YoY Growth | +15.73% | +18.25% | +24.59% | — | — | — | — |
| Operating Margin (Excl OI) % | 7.76% | 8.10% | 10.30% | 9.23% | 7.78% | 8.05% | 10.41% |
| Cons. Net Profit (₹ Cr) | -333.30 | 232.15 | 424.41 | 246.28 | 286.52 | 194.87 | 305.63 |
| QoQ Growth | -243.57% | -45.30% | +72.33% | -14.04% | +47.03% | -36.24% | — |
| YoY Growth | -216.33% | +19.13% | +38.86% | — | — | — | — |
| PAT Margin % | -3.64% | 4.24% | 6.59% | 5.32% | 7.92% | 4.77% | 6.34% |
Financial Performance: Margin Compression Drives Quarterly Loss
EID Parry's Q4 FY26 financial performance revealed a troubling disconnect between top-line growth and bottom-line profitability. Whilst net sales expanded 15.73% year-on-year to ₹7,882.33 crores, the company failed to translate this revenue momentum into earnings. On a sequential basis, sales declined 23.56% from Q3 FY26's ₹10,312.20 crores, reflecting the seasonal nature of the sugar business and softer demand conditions in the fertiliser segment.
The real damage occurred at the operating level. Operating profit before depreciation, interest, tax, and other income (PBDIT excl OI) stood at ₹611.49 crores in Q4 FY26, yielding a margin of just 7.76%—a sharp 265 basis points contraction from the 10.30% recorded in Q4 FY25. This marked the weakest quarterly margin since December 2024, indicating persistent cost pressures that management has struggled to mitigate through pricing power or operational efficiencies. Employee costs rose to ₹337.29 crores from ₹265.83 crores year-on-year, whilst other operating expenses remained elevated.
Interest costs climbed 23.11% year-on-year to ₹118.61 crores, reflecting higher working capital requirements and elevated debt levels despite the company's net cash position on an annual basis. Depreciation surged 59.24% to ₹225.66 crores, likely due to recent capacity expansions and asset additions. These factors combined to push profit before tax into negative territory at ₹162.34 crores—a dramatic reversal from the ₹734.54 crores profit recorded in Q4 FY25.
The tax line provided an additional blow, with the company booking a negative tax rate of 76.89%, resulting in a tax charge of ₹124.83 crores despite the pre-tax loss. This unusual situation—possibly stemming from deferred tax adjustments, non-deductible expenses, or tax provisions related to prior periods—magnified the consolidated net loss to ₹333.30 crores. The quality of earnings has clearly deteriorated, with the PAT margin collapsing to negative 3.64% from a healthy 7.92% in the year-ago quarter.
Critical Margin Pressure
EID Parry's operating margin (excluding other income) has contracted from 10.30% in Q4 FY25 to just 7.76% in Q4 FY26—a 265 basis point erosion that signals severe competitive and cost pressures. The company's inability to protect margins despite top-line growth raises concerns about pricing power and operational efficiency. With interest coverage deteriorating to 5.16 times (the lowest in recent quarters), financial flexibility is being tested.
Operational Challenges: Profitability Under Siege
The quarterly loss exposes fundamental challenges in EID Parry's core businesses—sugar, fertilisers, and nutraceuticals. The sugar division, which typically accounts for a significant portion of revenues, has faced headwinds from volatile cane prices, subdued sugar realisations, and regulatory constraints on pricing. The fertiliser segment, whilst benefiting from government subsidies, has contended with elevated raw material costs and intense competition from larger peers with better economies of scale.
Return on equity (ROE), a critical measure of capital efficiency, averaged 12.82% over recent years—significantly lower than the peer group average of approximately 23%. Whilst EID Parry maintains a healthy return on capital employed (ROCE) of 42.16%, the gap between ROCE and ROE suggests that the company's leverage profile and tax efficiency require attention. The latest quarter's loss will further depress ROE metrics, potentially pushing the trailing twelve-month figure into single digits.
On the balance sheet front, EID Parry has historically maintained a conservative capital structure with a net cash position (average net debt-to-equity of negative 0.26). However, working capital intensity has risen sharply, with current assets climbing to ₹16,318.59 crores as of March 2025 from ₹15,187.10 crores a year earlier. Trade payables stood at ₹7,507.78 crores, indicating stretched payment cycles. The company's cash flow from operations remained positive at ₹1,936 crores for FY25, but the recent quarterly loss raises questions about near-term cash generation.
Debt Servicing Capability Weakens
EID Parry's EBIT-to-interest coverage ratio fell to 5.16 times in Q4 FY26—the lowest in recent quarters—down from more comfortable levels above 8.0 times historically. Whilst the company maintains low absolute debt levels (debt-to-EBITDA of 0.67), the deteriorating interest coverage signals reduced financial flexibility. With interest costs rising 23.11% year-on-year to ₹118.61 crores, management must prioritise margin recovery to restore debt servicing comfort.
The Fertiliser Conundrum: Sector Headwinds Persist
EID Parry operates in a highly regulated and competitive fertiliser market, where government subsidy policies, raw material availability, and monsoon patterns dictate profitability. The company's fertiliser operations have faced margin pressures due to elevated phosphoric acid and ammonia prices globally, compounded by rupee depreciation. Whilst the government provides nutrient-based subsidies, delays in subsidy disbursements can strain working capital and impact realised margins.
The broader fertiliser sector has witnessed subdued demand growth, with agricultural commodity prices remaining under pressure and farmer sentiment affected by uneven monsoon distribution. EID Parry's positioning as a mid-sized player in a sector dominated by giants like Coromandel International and Chambal Fertilisers limits its bargaining power with suppliers and distributors. The company's efforts to diversify into speciality fertilisers and bio-pesticides have shown promise but remain too small to materially offset pressures in the core business.
Looking at peer comparison, EID Parry's operating margin of 7.76% lags behind Coromandel's more resilient margins and Chambal's cost-efficient operations. The company's integrated sugar-fertiliser model, whilst providing diversification benefits, has not delivered the margin stability that investors expected. With sugar prices facing regulatory caps and fertiliser margins compressed, the dual pressures have created a perfect storm for profitability.
| Company | P/E (TTM) | P/BV | ROE % | Debt/Equity | Div Yield % |
|---|---|---|---|---|---|
| EID Parry | 14.56 | 1.57 | 12.82% | -0.26 | — |
| FACT | 3,957.85 | 42.62 | 48.17% | 1.17 | 0.02% |
| Coromandel Inter | 27.39 | 4.34 | 19.79% | -0.07 | 0.97% |
| Chambal Fert. | 9.80 | 1.84 | 18.86% | 0.00 | 2.09% |
| Deepak Fertilis. | 20.91 | 2.81 | 16.02% | 0.55 | 0.69% |
| Paradeep Phosph. | 12.87 | 1.95 | 11.09% | 0.96 | 0.62% |
EID Parry's P/E ratio of 14.56 times appears reasonable relative to peers like Coromandel (27.39x) and Deepak Fertilisers (20.91x), but this masks the underlying earnings quality concerns. The company's ROE of 12.82% trails most competitors, whilst its price-to-book ratio of 1.57 times suggests limited valuation support. The absence of dividend yield further reduces the stock's attractiveness for income-seeking investors, especially when compared to Chambal's 2.09% yield.
Valuation Analysis: Premium Unjustified by Fundamentals
Despite the sharp 38.70% correction from its 52-week high, EID Parry continues to trade at what appears to be an unjustified premium. The stock's valuation grade remains "Very Expensive" according to proprietary metrics, with a P/E ratio of 14.56 times, EV/EBITDA of 3.38 times, and price-to-book of 1.57 times. Whilst these multiples have compressed from peak levels, they fail to adequately reflect the deteriorating earnings trajectory and margin pressures.
The company's PEG ratio of 0.98 suggests near-fair valuation when accounting for growth, but this metric becomes questionable given the recent quarterly loss and uncertain earnings outlook. Historical valuation patterns show the stock oscillating between "Fair" and "Very Expensive" grades over the past 18 months, with the current "Very Expensive" designation persisting since October 2024 despite the price decline. This suggests that earnings have fallen faster than the stock price, keeping valuations elevated.
Compared to peers, EID Parry's valuation appears relatively attractive on P/E basis but expensive when considering ROE and margin profiles. Chambal Fertilisers trades at just 9.80 times earnings with superior ROE of 18.86%, whilst Paradeep Phosphates commands a 12.87x multiple with comparable ROE of 11.09%. EID Parry's premium to these peers lacks fundamental justification, particularly given its weaker margin trajectory and recent loss.
Fair value estimation becomes challenging given the earnings volatility, but a conservative approach suggests the stock should trade closer to 10-12 times normalised earnings of approximately ₹80-90 per share (assuming recovery to historical profitability levels). This implies a fair value range of ₹800-1,080, with the current price of ₹764.05 offering limited margin of safety. Investors seeking entry should wait for clearer signs of operational turnaround and margin stabilisation before committing capital.
Shareholding Pattern: Institutional Confidence Wanes
EID Parry's shareholding pattern reveals subtle but concerning shifts in investor sentiment. Promoter holding has remained stable at 41.44% as of March 2026, unchanged from December 2025 but marginally lower than the 41.61% held a year earlier. The Murugappa Group's unwavering stake provides governance stability, but the lack of incremental promoter buying during the recent correction signals limited conviction in near-term recovery prospects.
| Quarter | Mar'26 | Dec'25 | Sep'25 | Jun'25 | Mar'25 |
|---|---|---|---|---|---|
| Promoter % | 41.44% | 41.44% | 41.49% | 41.54% | 41.61% |
| QoQ Change | 0.00% | -0.05% | -0.05% | -0.07% | — |
| FII % | 12.21% | 12.61% | 12.77% | 12.66% | 12.17% |
| QoQ Change | -0.40% | -0.16% | +0.11% | +0.49% | — |
| Mutual Fund % | 16.06% | 15.43% | 14.79% | 13.83% | 13.15% |
| QoQ Change | +0.63% | +0.64% | +0.96% | +0.68% | — |
| Insurance % | 0.23% | 0.44% | 0.39% | 0.28% | 0.34% |
| Non-Institutional % | 29.60% | 29.66% | 30.17% | 31.34% | 32.39% |
Foreign institutional investors (FIIs) reduced their stake to 12.21% in Q4 FY26 from 12.61% in the previous quarter, marking the second consecutive quarter of selling. This 40 basis point reduction, whilst modest in absolute terms, reflects global investors' diminishing appetite for the stock amid earnings concerns and sector headwinds. FII holding has remained range-bound between 12-13% over the past year, suggesting tactical trading rather than strategic accumulation.
In contrast, domestic mutual funds have steadily increased their stake from 13.15% in March 2025 to 16.06% in March 2026—a cumulative addition of 291 basis points over four quarters. This consistent buying by domestic institutional investors provides some support, though the pace of accumulation has moderated in recent quarters. The presence of 28 mutual fund schemes holding the stock indicates reasonable diversification of domestic institutional interest, though no single large fund appears to have built a significant overweight position.
Insurance companies' holdings collapsed from 0.44% to 0.23% in Q4 FY26, nearly halving their stake in a single quarter. This sharp reduction by risk-averse institutional investors signals concerns about the company's earnings stability and near-term outlook. Overall institutional holding stands at 28.95%, which remains healthy but has shown signs of erosion as FIIs and insurance companies trim positions.
Stock Performance: Severe Underperformance Across Timeframes
EID Parry's stock performance has been dismal across most timeframes, with the scrip significantly underperforming both the Sensex and its fertiliser sector peers. Over the past year, the stock has declined 22.38% whilst the Sensex fell just 7.50%, resulting in a negative alpha of 14.88 percentage points. This underperformance has accelerated in recent months, with the stock down 25.99% over six months versus the Sensex's 11.21% decline.
| Period | Stock Return | Sensex Return | Alpha |
|---|---|---|---|
| 1 Day | -3.32% | -0.63% | -2.69% |
| 1 Week | -3.29% | +1.08% | -4.37% |
| 1 Month | -9.63% | -0.85% | -8.78% |
| 3 Month | -12.84% | -7.59% | -5.25% |
| 6 Month | -25.99% | -11.21% | -14.78% |
| YTD | -26.21% | -10.81% | -15.40% |
| 1 Year | -22.38% | -7.50% | -14.88% |
| 2 Years | +22.22% | +0.79% | +21.43% |
| 3 Years | +54.82% | +21.61% | +33.21% |
| 5 Years | +81.77% | +48.99% | +32.78% |
The year-to-date decline of 26.21% has been particularly brutal, with the stock underperforming the Sensex by 15.40 percentage points. Within the fertiliser sector, EID Parry has lagged badly, with the sector index down just 11.16% over the past year—making EID Parry an 11.22 percentage point underperformer relative to peers. This suggests company-specific challenges beyond broader sector headwinds.
Technical indicators paint a uniformly bearish picture. The stock trades below all key moving averages—5-day (₹784.55), 20-day (₹814.03), 50-day (₹820.09), 100-day (₹867.98), and 200-day (₹968.85)—indicating strong downward momentum. The technical trend classification has deteriorated to "Mildly Bearish" as of May 25, 2026, with weekly MACD showing mildly bullish signals but monthly indicators remaining bearish. Bollinger Bands suggest continued bearish pressure, whilst the stock's high beta of 1.35 amplifies volatility in both directions.
On a longer-term basis, EID Parry has delivered impressive returns—up 54.82% over three years and 81.77% over five years, significantly outperforming the Sensex. This historical outperformance reflects the strong bull run in commodity and agri-linked stocks during the 2020-2023 period. However, the recent reversal suggests that cyclical tailwinds have turned into headwinds, and mean reversion is underway. The stock's current proximity to its 52-week low of ₹751.75 (just 1.64% away) suggests limited near-term downside cushion unless earnings stabilise quickly.
Investment Thesis: Quality Concerns Outweigh Valuation Appeal
EID Parry's investment case has weakened materially following the Q4 FY26 loss. The company's overall quality grade remains "Good" based on long-term financial performance, but recent trends suggest this rating may be at risk. The proprietary Mojo Score of 52 out of 100 places the stock firmly in "HOLD" territory, with the recommendation being "not recommended for fresh buy" whilst existing holders can continue to hold with caution.
The Mojo 4 Dots Analysis reveals mixed signals across key parameters. Near-term drivers show conflicting trends—quarterly financial trend remains classified as "Positive" based on some growth metrics, but technicals are "Mildly Bearish." Quality remains "Good" with zero debt, healthy institutional holdings, and strong average ROCE of 42.16%. However, valuation remains "Expensive" despite the correction, limiting the margin of safety. The overall assessment is "Mixed," reflecting the uncertainty surrounding the earnings trajectory.
Key strengths supporting the investment case include the company's zero-debt balance sheet, strong average ROCE of 42.16%, healthy institutional participation at 28.95%, and market leadership position in the fertiliser sector. The Murugappa Group's strong governance and execution track record provide some comfort. Additionally, the company's diversified revenue streams across sugar, fertilisers, and nutraceuticals offer resilience, though this diversification has failed to prevent the recent earnings collapse.
However, concerns significantly outweigh the positives at current levels. The quarterly loss, severe margin compression, weak ROE of 12.82% (well below peers), negative technical momentum, and year-long underperformance all point to fundamental challenges. The company's inability to protect margins despite revenue growth raises questions about competitive positioning and operational efficiency. With the stock trading at "Very Expensive" valuations despite the correction, risk-reward appears unfavourable for fresh investors.
Key Strengths & Risk Factors
KEY STRENGTHS ✓
- Zero-Debt Balance Sheet: Net cash position with average net debt-to-equity of negative 0.26 provides financial flexibility
- Strong ROCE: Average return on capital employed of 42.16% demonstrates efficient capital utilisation in core businesses
- Institutional Backing: Healthy institutional holdings of 28.95% with consistent mutual fund accumulation over past year
- Murugappa Group Pedigree: Part of respected conglomerate with strong governance and execution track record
- Diversified Revenue Streams: Presence across sugar, fertilisers, and nutraceuticals provides some cyclical protection
- Market Leadership: Largest company in fertilisers sector by market capitalisation
- Long-term Growth: 5-year sales CAGR of 14.64% demonstrates sustained top-line momentum
KEY CONCERNS ⚠
- Quarterly Loss: Consolidated net loss of ₹333.30 crores in Q4 FY26 marks first loss in recent years
- Severe Margin Compression: Operating margin contracted 265 bps YoY to 7.76%, lowest in recent quarters
- Weak ROE: Return on equity of 12.82% significantly trails peer average of ~23%
- Deteriorating Interest Coverage: EBIT-to-interest ratio fell to 5.16x, lowest level recorded
- Negative Tax Impact: Unusual negative tax rate of 76.89% amplified quarterly loss
- Bearish Technicals: Stock below all major moving averages with mildly bearish trend classification
- Severe Underperformance: 22.38% decline over past year vs Sensex's 7.50% drop; 11.22 percentage points behind sector
- Expensive Valuation: "Very Expensive" grade despite correction limits margin of safety
- FII Selling: Foreign institutions reduced stake for second consecutive quarter
Outlook: What to Watch for Recovery Signals
The path forward for EID Parry hinges on management's ability to arrest margin erosion and restore profitability in coming quarters. Investors should closely monitor sequential margin trends, cost management initiatives, and demand conditions in both sugar and fertiliser segments. Government policy decisions on sugar pricing, fertiliser subsidy disbursements, and agricultural support schemes will materially impact the company's earnings trajectory.
POSITIVE CATALYSTS 📈
- Margin Recovery: Sequential improvement in operating margins back above 9-10% levels
- Normalised Tax Rate: Return to standard 25-27% tax rate in upcoming quarters
- Raw Material Softening: Decline in phosphoric acid and ammonia prices globally
- Subsidy Disbursement: Timely release of pending government subsidies improving working capital
- Strong Monsoon: Normal to above-normal rainfall boosting fertiliser demand
- Sugar Price Uptick: Regulatory approval for higher sugar realisations
- Capacity Utilisation: Improved utilisation of recent capex driving operating leverage
RED FLAGS 🚩
- Continued Margin Pressure: Operating margins remaining below 8% for multiple quarters
- Working Capital Stress: Further deterioration in cash conversion cycle
- Promoter Selling: Any reduction in Murugappa Group's 41.44% stake
- FII Exodus: Accelerated foreign institutional selling below 10% threshold
- Debt Accumulation: Shift from net cash to leveraged position
- Market Share Loss: Ceding ground to larger peers in key markets
- Technical Breakdown: Breach of 52-week low at ₹751.75 on sustained basis
The immediate focus should be on Q1 FY27 results (due in August 2026) to assess whether the Q4 loss was an aberration or the start of a prolonged downturn. Management commentary on order books, pricing trends, and cost outlook will be critical. Any guidance on full-year margin expectations and volume growth targets would help restore investor confidence. Technical traders should watch for stabilisation above the ₹800 level and potential reclaim of the 20-day moving average at ₹814 as signs of trend reversal.
The Verdict: Cautious Hold with Limited Fresh Buying Appeal
Score: 52/100
For Fresh Investors: Avoid initiating positions until clear evidence of margin recovery and earnings stabilisation emerges. The quarterly loss, compressed margins, and bearish technical setup create an unfavourable risk-reward profile. Wait for at least two consecutive quarters of improving profitability and operating margins expanding above 9% before considering entry. A break below ₹750 would signal further downside risk.
For Existing Holders: Maintain positions with a defensive stance. The Murugappa Group's backing, zero-debt balance sheet, and long-term growth potential justify holding through this cyclical trough. However, set a mental stop-loss around ₹700-720 (approximately 10% below current levels) to limit downside in case of prolonged earnings deterioration. Use any rally towards ₹850-900 to reassess or reduce exposure. Monitor Q1 FY27 results closely for signs of turnaround.
Fair Value Estimate: ₹850-950 (11-24% upside potential), contingent on successful margin recovery to historical 9-10% levels and return to consistent quarterly profitability. Current price of ₹764 offers limited margin of safety given earnings uncertainty.
Rationale: Whilst EID Parry's long-term fundamentals remain intact with strong ROCE, zero debt, and institutional backing, the recent quarterly loss and severe margin compression warrant caution. The stock's "Very Expensive" valuation despite a 38% correction from highs, combined with bearish technical momentum and year-long underperformance, limits fresh buying appeal. Existing holders can maintain positions given the quality of promoters and balance sheet strength, but fresh investors should await clearer evidence of operational turnaround. The investment case will strengthen materially only if management demonstrates sustained margin recovery and earnings visibility over the next 2-3 quarters.
Note- ROCE = (EBIT - Other income)/(Capital Employed - Cash - Current Investments)
⚠️ Investment Disclaimer
This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results. All investments carry risk, including potential loss of principal.
